ArticleFrontiers in pharmacology2026

ACT001 synergizes with temozolomide-based chemoradiotherapy to cure refractory glioblastoma by targeting TNF-CXCL10-CD8

Ya Shu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.